D-1057-2017 Class II Terminated

Recalled by PD-Rx Pharmaceuticals, Inc. — Oklahoma City, OK

FDA drug recall D-1057-2017 was initiated by PD-Rx Pharmaceuticals, Inc. on Jul 28, 2017 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: out of specification for tablet weight. The recall status is terminated (terminated Dec 6, 2017). Affected quantity: 100 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 9, 2017
Initiation Date
Jul 28, 2017
Termination Date
Dec 6, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
100 bottles

Product description

Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30

Reason for recall

Failed Tablet/Capsule Specification: out of specification for tablet weight.

Distribution pattern

Nationwide

Code information

Lot: A17F55 Exp. 06/30/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1057-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1057-2017. Report a data issue: hello@regdatalab.com.